Functional dyspepsia and intestinal microbiota: is relationship possible?


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Background. Functional dyspepsia is a widespread disease that has a significant impact on the quality of life of patients; both dysbiotic changes in the intraluminal microbiota and the interaction of the microbiota of the intestinal mucosa with the immunity of the host organism can have significant importance in its pathogenesis. Objective: to reveal the features of intestinal microbiota in patients with functional dyspepsia. Methods. Fecal and blood samples were examined in 70 patients with functional dyspepsia, mean age 44 years. The examination of metabolites of microorganisms was carried out by gas chromatography and mass spectrometry according to G.A. Osipov. Results. In patients with functional dyspepsia, a decrease in the level of bacteria of the genera Bifidobacterim spp., Lactobacterium spp., excessive growth of representatives of the genera Eubacterium spp., Clostridium spp. and Klebsiella spp., aerobes of the genus Rhodococcus spp., the tendency to an excessive level of metabolites of fungi has been determined. Conclusion. The revealed dysbiotic changes in the composition of the luminal and parietal intestinal microbiota can have a significant importance in the pathophysiology of functional dyspepsia. Decrease in the level of anaerobic microorganisms contributes to the deterioration of colonization resistance of intestinal microbiocenosis and increases the risk of colon colonization by pathogenic microbiota, the formation of long-term chronic digestive disorders.

Full Text

Restricted Access

About the authors

Margarita Yu. Serkova

North-Western State Medical University n.a. I.I. Mechnikov

Email: serkova.margarita@yandex.ru
PhD, Teaching Assistant at the Department of Propaedeutics of Internal Diseases of Gastroenterology and Dietology 47, pav. 24, Piskarevsky Prospect, St. Petersburg 195067, Russian Federation

E. Yu Pavlova

North-Western State Medical University n.a. I.I. Mechnikov

Department of Propaedeutics of Internal Diseases, Gastroenterology and Dietology St. Petersburg

I. A Oganezova

North-Western State Medical University n.a. I.I. Mechnikov

Department of Propaedeutics of Internal Diseases, Gastroenterology and Dietology St. Petersburg

References

  1. Drossman D.A. Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features and Rome IV. Gastroenterology 2016;150:1262-79. Doi: 10.1053/j. gastro.2016.02.032.
  2. Андреев Д.Н., Заборовский А.В. и др. Эволюция представлений о функциональных заболеваниях желудочно-кишечного тракта в свете Римских критериев IV пересмотра (2016). РЖГГК. 2017;27(1):4-11.
  3. Koloski N.A., Jones M., Talley N.J. Evidence that independent gut-to-brain and brain-to-gut pathways operate in the irritable bowel syndrome and functional dyspepsia: a 1-year population-based prospective study. Aliment. Pharmacol. Ther. 2016;44:592-600. doi: 10.1111/apt.13738.
  4. Talley N.J., Ford A.C. Functional Dyspepsia. N. Engl. J. Med. 2015;373:1853-63. Doi: 10.1056/ NEJMra1501505.
  5. Sarnelli G., De Giorgi F., Atteo E., et al. Frequency, symptom evolution and pathophysiological correlates in prospectively identified patients with postinfectious dyspepsia. DDW. New Orleans. 2010. Abstract M2010.
  6. Corsetti M., Tack J. Mechanisms of functional dyspepsia and its relation to IBS. Irritable bowel syndrome. Diagnosis and treatment.Eds. M. Camilleri, M.C. Spiller, W.B. Saunders. London, 2002. P 117-26.
  7. Stanghellini V., Chan F.K., Hasler W.L., et al.Gastroduodenal disorders. Gastroenterology 2016;150(6):1380-92. Doi: 10.1053/j. gastro.2016.02.011.
  8. Drossman D.A., Haster W.L. Rome IV-Functional GI disorders: disorders of gut-brin interaction. Gastroenterology. 2016;150(6):1257-61. doi: 10.1053/j.gastro.2016.03.035.
  9. Simrén M., Barbara G., Flint H.J., et al. Rome Foundation Committee. Intestinal microbiota in functional bowel disorders: a Rome foundation report. Gut. 2013;62:159-76. Doi: 10.1136/ gutjnl-2012-302167.
  10. Bercik P., Denou E., Collins J., et al. The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice. Gastroenterology 2011;14:599-609. doi: 10.1053/j.gastro.2011.04.052.
  11. Минушкин О.Н., Топчий Т. Б. Функциональные гастроинтестинальные расстройства в определении Римских критериев-IV и некоторые лечебные подходы, зависящие от этого. Лечащий врач. 2018;5:84-8. [Minushkin O.N., Topchii T.B. Functional gastrointestinal disorders in the definition of Roman criteria-lV and some therapeutic approaches depending on it. Lechashchii vrach. 2018;5:84-8. (In Russ.)].
  12. Lupp C., Robertson M.L., Wickham M.E., et al. Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of enterobacteriaceae. Cell Host Microbe. 2007;2:204.
  13. Goodacre R. Metabolomics of a superorganism. J. Nutr. 2007;137(1):259-66. Doi: 10.1093/ jn/137.1.259S.
  14. Turnbaugh P.J., Ley R.E., Hamady M., et al. The human microbiome project. Nature. 2007;449(7164):804-10.
  15. Carabottia M., Sciroccoa A.,Masellib M.A. et al. The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems. Annals of Gastroenterology. 2015;28:203-209.
  16. Eckburg P.B., Bik E.M., Bernstein C.N., et al. Diversity of the human intestinal microbial flora. Science. 2005;308:1635-38.
  17. Ley R.E., Hamady M., Lozupone C., et al. Evolution of mammals and their gut microbes. Science. 2008;320:1647-51.
  18. Doré J., Blottière H. The influence of diet on the gut microbiota and its consequences for health. Curr. Opin. Biotechnol. 2015;32:195-99. doi: 10.1016/j.copbio.2015.01.002.
  19. Smith M.I., Yatsunenko T., Manary M.J., et al. Gut microbiomes of Malawian twin pairs discordant for kwashiorkor. Science. 2013;339:548-54. doi: 10.1126/science.1229000.
  20. De Filippo С., Cavalieri D., Di Paola М., et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. PNAS. 2010;107(33):14691-696. doi: 10.1073/pnas.1005963107.
  21. Samuel B.S., Gordon J.I. A humanized gnotobiotic mouse model of hostarchaeal-bacterial mutualism. Proc. Natl. Acad. Sci. USA. 2006;103(26): 10011-16.
  22. Lesniewska V., Rowland I., Laerke H.N., et al. Relationship between dietary-induced changes in intestinal commensal microflora and duodenojejunal myoelectric activity monitored by radiotelemetry in the rat in vivo. Exp. Physiol. 2006;91:229-37.
  23. Жиленкова О.Г., Быстрова О.В., Осипов Г.А. и др. Масс-спектрометрический анализ микробных метаболитов как экспрессный прием оценки состояния природных микробиоценозов в медицинской и санитарно-гигиенической практике. Лабораторная служба. 2016;5(3):43
  24. Gasbarrini A., Corazza G.R., Gasbarrini G., et al. Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome Consensus Conference. Aliment. Pharmacol. Ther. 2009;29(1):1-49. doi: 10.1111/j.1365-2036.2009.03951.x.
  25. Pyleris M., Giamarellos-Bourboulis E.J., Koussoulas B., et al. Small bowel culture confirms the presence of small intestinal bacterial overgrowth in a Subset of IBS subjects. Gastroenterology. 2011;140:152.
  26. Корниенко Е.А., Нетребенко О.К. Ожирение и кишечная микробиота: современная концепция взаимосвязи. Педиатрия. 2012;91(2):110- 22.
  27. Шаликиани Н.В., Бакулин И.Г., Дубинкина В.Б. и др. Особенности состава микробиоты кишечника у пациентов с алкогольным циррозом печени. Терапевтический архив. 2015;87(12):59-65
  28. Paun A., Yau C., Danska J.S. The influence of the microbiome on type 1 diabetes. J. Immunol. 2017;198:590-95. Doi: 10.4049/ jimmunol.1601519.
  29. Pawlik B., Macura A.B., Biaek-Kaleta J. Presence of fungi in stool of children. J. Med Dosw. Microbiol. 2002;54(3):2739.
  30. Buhner S., Li Q., Vignali S., et al. Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome. Gastroenterology 2009;137(4):1425-oi: 10.1053/j.gastro.2009.07.005.
  31. Шептулина А.Ф., Ивашкин В.Т. Синдром раздраженного кишечника через призму кишечного микробиома. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2016;26(6):120-23.
  32. McIntosh K., Reed D.E., Schneider T. FODMAPs alter symptoms and the metabolome of patients with IBS: a randomised controlled trial. Gut. 2017;66(7):1241-51. Doi: 10.1136/ gutjnl-2015-311339
  33. Осипов Г.А., Родионов Г.Г. Применение метода масс-спектрометрии микробных маркеров в клинической практике. Спецвыпуск. Лаборатория. 2013;2:68-73
  34. Осипов Г.А., Новикова В.П. Методика масс-спектрометрии микробных маркеров как способ оценки пристеночной кишечной микро биоты при заболеваниях органов пищеварения. Учебно-методическое пособие. СПб., 2013:83 с
  35. Kedlaya I., Michael B.I., Sammy S.W. Rhodococcus equi infections in immunocompetent hosts: case report and review. Clin Infect Dis. 2001; 32(3):39-46.
  36. Bouhnik Y., Flourie B., D'Agay-Abensour L., et al. Administration of transgalac-to-oligosaccherides increases fecal bifidobacteria and modifies colonic fermentation metabolism in healthy humans. J. Nutr. 1997;127:444-48.
  37. Ropert A., Cherbut C., Roze C., et al. Colonic fermentation and proximal gastric tone in humans. Gastroenterology. 1996;111:289-96.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies